Back to UBS Group AG UBS Group AG

AIDXAIDX
2 quarters

Position history for UBS Group AGUBS Group AG's holdings in 20/20 BIOLABS INC

UBS Group AG holds 3 shares of AIDX (20/20 BIOLABS INC), worth $2 as of 2026-Q2. The position was decreased (-100.0% shares).

Current Value

$2

Current Shares

3

Total Value Change

-$15,629

Total Shares Change

-8,311

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3
-100.0%
$20.0%$0.55
0
2026-Q1
New
8,314
-
$15,6310.0%$1.88
28

Other major holders of AIDX: Cresset Asset Management, LLC, CITADEL ADVISORS LLC, VANGUARD FIDUCIARY TRUST CO, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used